|
2009-08-21 |
Zinc Supplement in ill persons with ataxia type SCA-2. |
CIDEM |
Registered |
|
2009-08-20 |
Effectiveness and Safety of use ior LeukoCIM as prophylaxis and treatment of Neutropenia in patients with HIV / AIDS. |
CIMAB |
Registered |
|
2009-07-24 |
Impact of the Granulocytes Colony-Stimulating Factor (ior-LeukoCIM) in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients. |
CIMAB |
Registered |
|
2009-07-24 |
Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study. |
CIMAB |
Registered |
|
2009-07-10 |
Effectiveness and Safety of ior EPOCIM in patients with Chronic Renal Failure on dialysis methods. |
CIMAB |
Registered |
|
2009-07-03 |
Amniotic Membrane Transplantation vs Conjunctival–Limbal Autograft for Primary Pterygium |
HHA |
Registered |
|
2009-07-03 |
Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy. |
CIMAB |
Registered |
|
2009-07-03 |
Impact of Human Recombinant Erithoropoietin (ior EPOCIM) in cancer patients with post Chemo and Radiotherapy induced anemia. |
CIMAB |
Registered |
|
2009-07-03 |
Safety evaluation of Recombinant Human Erythropoietin ior EPOCIM in the treatment of patient with cerebral infarction acute. Study Stage I. |
CIMAB |
Registered outdated |
|
2009-07-03 |
Therapeutic Equivalence between ior EPOCIM and EPO without albumin, for patients with Chronic Renal failure on Peritoneal dialysis methods.(Hemodialysis or peritoneal dialysis). |
CIMAB |
Registered |
|
2009-05-29 |
rTMS-stroke-phase I |
CIREN |
Registered |
|
2009-03-13 |
Clinical evaluation of the effect anti-inflammatory of the extract of Mangifera indica L. (Vimang®) in patients with diagnosis of Bronchial Asthma |
CQF |
Registered |
|
2009-02-11 |
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. |
CIGB |
Registered |
|
2009-02-11 |
Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis. |
CIGB |
Registered |
|
2008-09-12 |
Challenge study to determine the protective efficacy of a single oral dose of the attenuated 638 strain. |
FINLAY |
Registered |
|
2010-12-17 |
Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors. |
CIM |
Registered |
|
2010-12-17 |
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III. |
CIM |
Registered |
|
2010-12-17 |
99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II |
CIM |
Registered |
|
2010-12-17 |
NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II |
CIM |
Registered |
|
2009-02-11 |
Recombinant interferon alpha-2b in paranoid schizophrenia. |
CIGB |
Registered |
